Back

Safety and efficacy of transendocardial injection of induced-pluripotent stem cells-derived mesenchymal cells in a swine subacute model of myocardial ischemia.

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Basic Science: Gene and cell therapy Gene and cell therapy HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Andreu Climent

Polytechnic University of Valencia, Valencia (Spain)

11 More presentations in this session

Presentation thumbnail
HFWM: C-kit+ resident cardiac stem cells improve left ventricular fibrosis in pressure overload
Doctor A. Kazakov (Homburg, DE)
Abstract Slides
Presentation thumbnail
HFWM: An in vivo selection strategy for the identification of novel cytokines inducing cardiac retention of murine mesenchymal stromal cells after myocardial infarction
Miss F. Bortolotti (Trieste, IT)
Abstract
Presentation thumbnail
HFWM: The H19 long non-coding RNA regulates pathological cardiac hypertrophy
Presentation thumbnail
Safety and efficacy of first in-human use of muscle-derived stem cells transfected with connexin-43 gene for chronic heart failure
Professor E. Straburzynska-Migaj (Poznan, PL)
Abstract
Presentation thumbnail
A combined cellular and surgical ventricular reconstruction therapeutic approach produces attenuation of remodeling in infarcted rats
Doctor C. Kapelios (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Basic Science: Gene and cell therapy

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources